All In MedTech

FDA Clearance Tracker · P200035-S038

OrganOx metra® System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 9, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 9, 2026

Approved

Time to decision

168 days

Received Apr 24, 2026. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P200035-S038
Device name
OrganOx metra® System
Applicant location
Oxford
Received
Apr 24, 2026
Decided
Oct 9, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P200035

Device type

Device class
Class III

Every decision under product code QQK

FDA's approval statement

As written in FDA's record.

changing the supplier of the Blood Reservoir, minor manufacturing process changes for the filter materials, and increasing the wall thickness of the five (5) tubing segments in the blood circulation loop of Disposable Set (D0146/D0146-US)

Source documents

Other decisions for Organox Limited

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.